Sedana Medical AB (publ) (STO: SEDANA)

Market Cap	1.20B
Revenue (ttm)	174.14M
Net Income (ttm)	-57.24M
Shares Out	99.34M
EPS (ttm)	-0.58
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	71,893
Open	10.70
Previous Close	10.68
Day's Range	10.68 - 10.92
52-Week Range	10.40 - 28.60
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 24, 2024

About Sedana Medical AB

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; and Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care, as well as AnaConDa, a medical device enabling ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 79
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: SEDANA

Financial Performance

In 2023, Sedana Medical AB's revenue was 153.87 million, an increase of 25.23% compared to the previous year's 122.87 million. Losses were -59.61 million, -18.90% less than in 2022.